SCHEDULE 13D/AAccepted Sep 8, 5:08 PM ET
Apogee Therapeutics, Inc. SCHEDULE 13D/A
Accepted (ET)
5:08 PM
Sep 8, 2026
Filed
Sep 8, 2026
Documents
4
Size
37.0 KB
Summary
Summary not available
This filing does not have a written summary yet. You can still open the original filing and its exhibits.